Posts Tagged ‘child drugging’

ADHD: Has this diagnostic fad run its course?

Friday, August 20th, 2010

“On a societal level, we take responsibility for the fact that the diagnostic labels we have accepted, and pharmacological interventions we have embraced, are harming children and that we have no right to ask children to bear those harms. On a personal level, we place the difficulties of childhood within the context of the life of each child, and within the nature of childhood itself. We make a commitment to helping children be their best selves, and above all, we do the best we can to make sure that we never use our positions of authority to harm anyone.” Professor Stephen R. Herr

The Christian Science Monitor

August 20, 2010

The idea of Attention Deficit Hyperactivity Disorder (ADHD) as a credible diagnostic term has passed and it is time that we accept that and move on. Fads and disappointments are not new to the field of psychology nor is the need for people to get beyond them.

Phrenology,  hysteria, eugenics, compulsory sterilizations, shock therapy, and Thalidomide all at one time had some grounding in hope and reason. For awhile, each of them captured the imagination, but over time each led to more pain than good, and for that reason they all got left behind.

Like diagnostic fads before it, ADHD has been in many ways a disorder of its time.

Previous diagnostic fads

Hysteria found expression in a Victorian-era society that vigorously attempted to constrain the lives of women. The eugenics movement addressed societal concerns of the early 20th century relating to burgeoning minority populations.

ADHD became a popular diagnosis in the 1980s as more parents went to work and the role of schools and teachers changed. If we look at the history of our culture and the ailments that have plagued it, is not difficult to see why people in positions of authority told women that they were weak, minorities that they were feeble-minded, and children that they had a psychological disorder: It was easier for them than addressing the difficult conditions that women, minorities, and children faced.

At one time, ADHD appeared to be a reasonable theory that might help people address genuine concerns.  Raising children can be hard,  especially when adults are tired, frustrated, overwhelmed, and riddled with self-doubt. Beyond that, children can be annoying; They fidget, they interrupt, they don’t pay attention, and they don’t always do what they are told.

The behaviors of children and the difficulties of adults often lead to guilt, worry, and a sense of wrong that concerned adults feel a responsibility to address. The creation of ADHD as a psychological disorder was in part an attempt to deal with some of the difficulties of raising children. Unfortunately, that attempt has fallen short and led to new problems in recent years.

On a diagnostic level, ADHD is problematic. After generations of research, there is still no test for ADHD, nor is there a standard diagnostic measure within the profession.

A huge – and lucrative – market

What started out as a theory articulated by professionals is now an urban legend. Parents, teachers, talk show hosts, friends, neighbors and even the person you’re standing next to in the grocery store each believe that they can diagnose and treat ADHD. This superfluity of focused misinformation has helped fuel a pharmacological intervention that would have seemed absurd two generations ago. As of 2006, 4.5 million kids have been diagnosed with ADHD, with nearly half taking medication. In 2008, the ADHD pharmaceutical market was worth $4 billion.

Another problem with our fixation on ADHD is that it is not working. Again, even after generations of research there is no evidence that suggests placing children on Schedule II drugs such as Ritalin, Adderall, or Vyvanse improves their intellectual abilities over an extended period, or that these drugs affect children with ADHD any differently than they affect any other child. A stimulant is a stimulant is a stimulant. What we do know is that the use of these drugs can be debilitating, addictive, and deadly.

And just this week, a Michigan State University study found that nearly one million children in America are potentially misdiagnosed with ADHD – in large part because they were the youngest and least mature in their kindergarten classes.

Maybe the greatest problem regarding ADHD as a diagnostic label is that our faith in that label has distracted us and kept us from looking for the better understandings we should be seeking. Stress and sleeplessness lead to inattention. Frustration leads to anger and rebellion. Depression leads to indifference and a lack of enthusiasm.

Probably one of the best ways to make sense of children and the rise of ADHD is for adults to focus on some basic questions. Don’t most adults become distracted when they are tired? Don’t most adults become fidgety when they are bored? Don’t most adults lose interest in their work when they don’t see any significance in what they are doing? And when adults wrestle with concerns relating to stress, sleeplessness, frustration, and depression, aren’t the responses often “get some rest,” “exercise” “start eating better,” and “try finding something you’re interested in”?

As adults, aren’t some of our most meaningful discussions about how to live a meaningful life? If that’s the case for adults, why don’t we put more emphasis on these sorts of answers for children? Wouldn’t more rest, better meals, more exercise, and a greater focus on helping children understand their interests serve most children well?

Read the rest of this article here:  http://www.csmonitor.com/Commentary/Opinion/2010/0819/ADHD-Has-this-diagnostic-fad-run-its-course

« Return to news items


  • Share/Bookmark

Glaxo Still Haunted by Faked Paxil Studies in Kids; Crooked psychiatrist expected to plead guilty to criminal charges today

Thursday, August 19th, 2010

“The use of Paxil in children became extremely controversial after it emerged that GSK knew for 15 years, but didn’t tell anyone until 2006, that the drug may carry a risk for suicide. The drug now carries a black-box warning for suicide risk in children.”

BNET
By Jim Edwards
August 19, 2010

A crooked doctor who faked data in a GlaxoSmithKline (GSK) study of the antidepressant Paxil in children pled guilty to criminal charges today, causing groans among GSK’s senior management as the company hopes to fend off a different criminal investigation into whether it manipulated clinical data on its diabetes drug, Avandia. She was sentenced to 13 months in prison.

The two cases are technically completely separate, but they’re both about data manipulation. GSK has been accused of sitting on data showing risks on both drugs; and the FDA previously shut down one of GSK’s factories where both drugs were made.

Thus, the expected guilty plea of Dr. Maria Carmen Palazzo today is a reminder to managers everywhere that cutting ethical corners can cause unwanted chickens to return to their roosts, even years later.

Palazzo was indicted in 2007 on 40 counts of defrauding Medicare and Medicaid at her New Orleans clinic, and 15 counts of conducting fraudulent clinical trials. The charges followed an FDA accusation that she had enrolled 26 children in studies of Paxil for obsessive-compulsive disorder and major depressive disorder. She included children in the trial — which was given the cutesey nickname “Kiddie-Sads-Present and Lifetime” — who did not have the diagnoses being studied. GSK gave her more than $5,000 for each child she enrolled.

At trial, Palazzo was convicted on 39 counts of healthcare fraud and was sentenced to 87 months in prison and forfeiture of $655,000. The clinical trial fraud charges were thrown out, but prosecutors appealed and won a ruling this year reinstating those charges. That appears to be the reason Palazzo is reappearing in court to make a plea.

The use of Paxil in children became extremely controversial after it emerged that GSK knew for 15 years, but didn’t tell anyone until 2006, that the drug may carry a risk for suicide. The drug now carries a black-box warning for suicide risk in children.

Read entire article here:  http://www.bnet.com/blog/drug-business/10-years-later-glaxo-still-haunted-by-faked-studies-of-paxil-in-kids/5545

Read more about Palazzo here:
http://medicaresmostwanted.blogspot.com/2007/06/dr-maria-carmen-palazzo-has-been.html

« Return to news items


  • Share/Bookmark

USA Today: Researchers say nearly 1 million kids diagnosed “ADHD” simply because they’re youngest in their class

Tuesday, August 17th, 2010

USA Today
By Liz Szabo
August 17, 2010

Nearly 1 million children may have been misdiagnosed with attention deficit hyperactivity disorder, or ADHD, not because they have real behavior problems, but because they’re the youngest kids in their kindergarten class, researchers say.

Kids who are the youngest in their grades are 60% more likely to be diagnosed with ADHD than the oldest children, according to a study out today from Michigan State University, given exclusively to USA TODAY. A second study, by researchers at North Carolina State University and elsewhere, came to similar conclusions. Both are scheduled for publication in the Journal of Health Economics.

TEENS: 1/3 with ADHD drop out or delay graduation

About 4.5 million children have been diagnosed with ADHD, according to the studies.

Misdiagnosing children can have long-lasting effects, says assistant professor of economics Todd Elder, author of the Michigan State study. In fifth and eighth grade, the youngest kids in a class were more than twice as likely to use Ritalin, a stimulant commonly prescribed for ADHD, compared with the oldest students, his study says.

While many parents say Ritalin has helped their kids, it also can have significant side effects, causing headaches, dizziness and even high blood pressure, according to the paper from North Carolina State.

The findings could influence the way that teachers evaluate children with ADHD symptoms — as well as complicate parents’ decisions about when to start children in kindergarten, Elder says.

Read entire article here:  http://www.usatoday.com/news/health/2010-08-17-1Aadhd17_ST_N.htm

« Return to news items


  • Share/Bookmark

The BBC—new report challenges psychiatry’s billing bible, the DSM—”Mental Health: Are we all sick now?”

Wednesday, July 28th, 2010

BBC News
By Philippa Roxby
July 28, 2010

Diagnosing psychiatric illness has always been controversial, mental health experts say. Now some are worried that a new draft of the diagnostic ‘bible’ for mental health medicine could result in almost everyone being diagnosed with a mental condition.

The diagnostic ‘bible’ in question is the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association.

The US manual is used worldwide as a basis for diagnosis, research and medical education.

Its forthcoming fifth edition – known in the profession as as DSM-5 – is set to contain a range of new diagnoses, including conditions such as “mixed anxiety depression, psychosis risk syndrome and temper dysregulation disorder”, as well as the more mundane binge eating.

The danger, say experts writing in a special issue of the Journal of Mental Health, is that there has not been enough research to back up these changes.

Even the smallest shift in how to define something like depression could have huge implications.

Self-fulfilling

Dr Felicity Callard, senior research fellow at the Institute of Psychiatry, King’s College London, says it is crucial to understand what happens when people are over-diagnosed.

“There are very big potential implications on how people, particularly adolescents, respond to being told they have a mental illness. It’s likely there will be harmful consequences,” she said.

She cites the “at risk psychosis syndrome” diagnosis as an example of a label which is given to young people who ‘might’ have psychosis – characterised by abrupt changes in personality. It is a diagnosis of something which could result in a disorder, but only potentially. That can have complicated effects, she says.

“Imagine a young person being told that they are “at risk” of developing a mental illness. How would that affect that individual’s behaviour? Could it lead to increased stigma or even discrimination? And how might it affect the parents and family of that person too?”

Jerome Wakefield of New York University’s Department of Psychiatry writes: “One of the most frightening scenarios is the potential for medicating people – particularly children – who haven’t yet shown any signs of illness in a bid to ‘treat’ them.”

These concerns are shared by a number of clinical experts in the Journal of Mental Health.

Read entire article here:  http://www.bbc.co.uk/news/health-10787342

« Return to news items


  • Share/Bookmark

The malicious use of pharmaceuticals: An under-recognized form of child abuse

Thursday, July 22nd, 2010

Physorg.com
July 22, 2010

Child abuse is a serious problem that affects nearly one million children a year in the United States alone. The American Academy of Pediatrics and the US Department of Health and Human Services classify child abuse into four categories including neglect, physical abuse, sexual abuse, and emotional abuse. None of these categories, however, clearly includes the abusive use of drugs on children. A study soon to be published in the Journal of Pediatrics investigates the malicious use of pharmaceuticals and attempts to shed light on this under-recognized problem.

Dr. Shan Yin from the University of Colorado and the Rocky Mountain Poison Drug Center at Denver Health reviewed cases of pharmaceutical abuse reported to the National Poison Data System between 2000 and 2008. Dr. Yin included reports of the malicious use of alcohol, painkillers, cough and cold medicines, sedatives and sleeping pills, and antipsychotic medicines.

Of the more than 1400 cases studied, nearly 14% resulted in moderate to major consequences, including death. Nearly one-half of the abused children were exposed to at least one sedative. An average of 160 cases, including two deaths, was reported each year. Motives and legal findings were unavailable for these particular cases; however, motives for the abusive use of drugs generally are varied, and can include punishment, amusement, or a wish for a break from childcare responsibilities.

This study illustrates the seriousness of the abusive use of drugs administered to children.

Read entire article:  http://www.physorg.com/news198936684.html

« Return to news items


  • Share/Bookmark

Death of 7-year old prompts Florida officials to ask FDA to forbid allowing foster kids as guinea pigs in drug trials

Monday, July 19th, 2010

Pharmalot
By Ed Silverman
July 19, 2010

Last year, a 7-year-old foster boy named Gabriel Myers committed suicide in Florida and, after reams of publicity and hand-wringing over the use of psychotropic medications in such children, a state task force recommended, among other things, that children never be allowed to participate in a clinical trial designed to evaluate new psychotropic meds or whether such drugs approved for adults should be given to children.

The move was prompted, in part, because a Florida psychiatrist, Sohail Punjwani, who treated the boy before he committed suicide, received an FDA warning letter for failing “to protect the rights, safety and welfare” of children enrolled in clinical trials (back story). Before the suicide, the psychiatrist prescribed to kids several drugs, some of which weren’t approved by the FDA for use on children and had been linked to dangerous side effects, including an increased risk of suicide among children (back story).

As part of the follow-up, George Sheldon, who head’s Florida’s Department of Children and Families, wrote FDA commish Margaret Hamburg for info about any foster children who might have participated in clinical trials for psychotropic meds (read the letter) and asked the FDA to forbid foster kids from participating in these trials. Last month, the agency wrote back to say the agency does not agree with a “blanket prohibition” on enrolling foster children. Why? Such a policy fails to account for the greater risk of off-label prescribing and research involving children can yield benefits that cannot be obtained by tracking usage in adults, Jill Warner, acting associate commissioner for the FDA’s Special Medical Programs, wrote back (see here). Drugmakers, by the way, also have something at stake – they receive an extra six months of marketing exclusivity in return for having conducted the pediatric trials.

We asked Florida officials if they are rethinking their position. The answer? No way. The state is resolute.

Read entire article:  http://www.pharmalot.com/2010/07/florida-tells-fda-no-children-in-psychotropic-trials/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+Pharmalot+%28Pharmalot

« Return to news items


  • Share/Bookmark

Hidden Facts About Ritalin; Side Effects include brain damage, psychosis, severe dependence, paranoia

Monday, July 5th, 2010

New With Views
By Jon Rappoport
July 5, 2010

In 1986, The International Journal of the Addictions published a very important literature review by Richard Scarnati. It was called “An Outline of Hazardous Side Effects of Ritalin (Methylphenidate)” [v.21(7), pp. 837-841].

Scarnati listed a large number of adverse affects of Ritalin and cited published journal articles which reported each of these symptoms.

For every one of the following Ritalin effects, there is at least one confirming source in the medical literature:

• Paranoid delusions
• Paranoid psychosis
• Hypomanic and manic symptoms, amphetamine-like psychosis
• Activation of psychotic symptoms
• Toxic psychosis
• Visual hallucinations
• Auditory hallucinations
• Can surpass LSD in producing bizarre experiences
• Effects pathological thought processes
• Extreme withdrawal
• Terrified affect
• Started screaming
• Aggressiveness
• Insomnia
• Since Ritalin is considered an amphetamine-type drug, expect amphetamine-like effects
• Psychic dependence
• High-abuse potential DEA Schedule II Drug
• Decreased REM sleep
• When used with antidepressants one may see dangerous reactions including hypertension, seizures and hypothermia
• Convulsions
• Brain damage may be seen with amphetamine abuse.

Many parents around the country have discovered that Ritalin has become a condition for their children continuing in school. There are even reports, by parents, of threats from social agencies: “If you don’t allow us to prescribe Ritalin for your ADHD child, we may decide that you are an unfit parent. We may decide to take your child away.”

This mind-boggling state of affairs is fueled by teachers, principals, and school counselors, none of whom have medical training. Yet even if they did…

The very existence of the “illnesses” for which Ritalin would be prescribed is unproven. It is merely assumed.

In commenting on Dr. Lawrence Diller’s book, Running on Ritalin, Dr. William Carey, Director of Behavioral Pediatrics, Children’s Hospital of Philadelphia, has written, “Dr. Diller has correctly described… the disturbing trend of blaming children’s social, behavioral, and academic performance problems entirely on an unproven brain deficit…”

On November 16-18, 1998, the National Institute of Mental Health held the prestigious “NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder [ADHD].” The conference was explicitly aimed at ending all debate about the diagnoses of ADD, ADHD, and about the prescription of Ritalin. It was hoped that at the highest levels of medical research and bureaucracy, a clear position would be taken: this is what ADHD is, this is where it comes from, and these are the drugs it should be treated with. That didn’t happen, amazingly. Instead, the official panel responsible for drawing conclusions from the conference threw cold water on the whole attempt to reach a comfortable consensus.

Read entire article:  http://www.newswithviews.com/Rappoport/jon101.htm

« Return to news items


  • Share/Bookmark

Psychiatric Drug Abuse of Foster Care Kids Costs Government Billions; Feds now investigating potentially massive fraud

Wednesday, June 16th, 2010

Politics Daily
By David Sessions
June 16, 2010

Seven-year-old Gabriel Meyers didn’t want soup for lunch one Thursday in April, 2009. When his 23-year-old foster brother sent Gabriel to his room for dumping his soup in the trash, Gabriel threatened to kill himself. He kicked his toys around his room, then locked himself in the bathroom.

Police reports say Gabriel was home sick that day from his elementary school in Margate, Fla., under the care of Miguel Gould, his foster father’s son. Around 1:00 p.m., city police responded to Gould’s frantic 911 call and found Gabriel had hanged himself.

A troubled child who had previously suffered from neglect, sexual assault, and abusive parenting, Gabriel spent the previous year shuttling among several foster parents while taking a constellation of antipsychotic medicines, including Lexapro and Vyvanse, to control his depression and attention deficit hyperactivity disorder. Like most children in Florida state foster care, Medicaid paid Gabriel’s medical expenses.

Just one month before his suicide, Gabriel’s doctor prescribed him Symbyax, an anti-depressant restricted for treatment of children. The medication’s FDA-required label features a warning that use of the drug by children or teenagers can lead to suicide.

Symbyax does not meet criteria established by Congress for Medicaid reimbursement., so it is illegal for Medicaid to pay for a prescription of the drug to a child. Sohail Punjwani, the doctor who prescribed Gabriel’s Symbyax, received a stern letter from the FDA about his history of over-prescribing mental health drugs.

According to a number of foster care experts who spoke with Politics Daily, children in foster care, who are typically concurrently enrolled in Medicaid, are three or four more times as likely to be on antipsychotic medications than other children on Medicaid. Alarmingly, many of these drugs are medically prohibited for minors and dangerous to the children taking them. Often young patients under state supervision are also prescribed three or four high-risk drugs at a time — all paid for by Medicaid.

State foster care programs and child protective services have had mixed success addressing the pervasiveness of dosing their clients with prescription psychotropic drugs. Using federal Medicaid monies to purchase dangerous prohibited prescriptions for children, which cost the government up to $600 per dose, is technically a violation of the law.

Now, the Senate Subcommittee on Oversight of Government Management, chaired by Democratic Sen. Daniel Akaka of Hawaii, has asked the Government Accountability Office to look into the drugging of foster care children. The investigators will attempt to account for estimates in the hundreds of millions of dollars of possible fraud arising from prescriptions for drugs explicitly barred from Medicaid coverage. The GAO is collecting data from Oregon, Massachusetts, Florida, Maryland, Minnesota, and Texas, to search for patterns of abuse. This effort marks the first time suspicion of Medicaid fraud related to psychotropic drugs has been examined at the federal level. According to Senate staffers working on the investigation, the committee will likely hold hearings on the matter later this year.

Read entire article:  http://www.politicsdaily.com/2010/06/17/psychotropic-drug-abuse-in-foster-care-costs-government-billions/

« Return to news items


  • Share/Bookmark

“Drugging Pre-School Children: A crime against childhood—children as young as 2 prescribed powerful anti-psychotics”

Thursday, June 10th, 2010

The MetroWest Daily News
By Jacob Azerrad
June 10, 2010

In 2001, Harry Markopolos repeatedly warned the authorities about Bernie Madoff. No one listened. Only a serious downturn in the economy led to Madoff’s downfall. It’s not a Ponzi scheme, but once again, no one is listening and the red flags are everywhere. This time the victims are our very young, innocent children in the millions. Today, children as young as 2, are being prescribed powerful anti-psychotic medications. Side effects include tics, drooling, and incessant eating. Some children have gained up to 100 pounds and often progress to becoming diabetic.

Virtually nothing is known about the long-term impact of these medications. And no one seems to care. Certainly not the drug companies pushing these drugs, nor the doctors who have been coerced by the pharmaceutical industry and panicking parents alike into prescribing them. The increase in the use of anti-psychotics is directly tied to the rising incidence of one particular diagnosis, bipolar disorder. Experts estimate that the number of kids with this diagnosis is now more than one million and rising, making it more common than autism and diabetes combined. To treat it, doctors are administering medications that have yet to be approved for children. Mothers are legally medicating their two-year-olds with Risperdal to quiet their tantrums, Trileptal to stabilize their moods, and Clonidine to help them sleep.

This is not the old story about ADD or ADHD and the use of Ritalin or other approved drugs in use since the 1970′s. This is not about helping the child who fidgets and can’t concentrate in their elementary school classroom. This is about tens of thousands of energetic, outgoing, healthy, and normal 3- and 4-year-olds who just won’t sit still in Mommy and Me. It is those children who have now been diagnosed with a new and controversial diagnosis – Childhood Bipolar Disorder.

On Sept. 4, 2007, The New York Times stated that studies in the 1970s and 80s concluded bipolar disorder was rare in children, but between 1994 to 2003, there was an astounding 40-fold increase in the number of children diagnosed with bipolar disorder.

In a 2007 “60 Minutes” episode, Katie Couric focused on the short life of 4-year-old Rebecca Riley of Hull. Diagnosed with bipolar disorder at age 28 months, she was dead one year later from an overdose of a psychotropic drug cocktail. At one point, Couric asks Rebecca’s mother, who had been charged with her daughter’s murder, if she thought her child’s behavior might have been normal. That in fact, maybe little Rebecca was just exhibiting Terrible Two’s behavior.

On Nov. 19, 2008, the New York Times reported that 31 children who were diagnosed with Childhood Bipolar Disorder and given the drug Risperdal for tantrums died, and 1,176 suffered serious side effects.

Read entire article:  http://www.metrowestdailynews.com/opinion/x1602634540/Azerrad-Drugging-pre-school-children-A-crime-against-childhood

« Return to news items


  • Share/Bookmark

42 percent of all kids in foster care are taking three or more mood-altering drugs

Monday, June 7th, 2010

NewsTimes.com
By Eileen FitzGerald
June 7, 2010

Here’s just one statistic that Danbury school psychologist Charles Manos worries about: 42 percent of all kids in foster care are taking three or more mood-altering drugs.

“All kids in foster care have some story of trauma, like abuse or neglect, so we need to ask the question `How are we dealing with trauma?’” Manos asked.

Overall, children are receiving more prescriptions than ever before to treat medical, emotional and psychological problems, according to a May report from Medco Health Solutions.

More than one in four children with health insurance in the U.S., and nearly 30 percent of all children from 10 to 19, take at least one prescription to treat a chronic condition. The most substantial increases over the past nine years have been in antipsychotic, diabetes and asthma drugs, according to the Medco report.

In some cases, students take medications at home. In many cases, school nurses dispense it.

For instance, Danbury schools health coordinator Sue Levasseur said 80 middle school students receive asthma medication each day at school and another 14 to 15 children receive a psychotropic drug at school.

Part of the school system’s job is to educate parents, said Manos, who has worked in local schools for more than 30 years and also has a private practice.

“I think we have become a society that says it’s OK to medicate the symptoms of kids. Medication is easier. I think as a society we are quick to change behavior rather than understand it,” Manos said.

Behavior medications can be destructive if used improperly, he said.

“Say there is abuse or trauma, and we don’t do an adequate analysis. Then we silence the symptoms through the medications,” Manos said.

“The fact is that medication does not treat a disorder, it treats the symptoms of the manifestation, and people don’t understand that. I think there is a myth that medication treats the disorder.”

Read entire article:  http://www.newstimes.com/news/article/Growing-numbers-of-children-on-medication-514614.php

« Return to news items


  • Share/Bookmark